H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses
Kutubuddin Mahmood(Novavax (United States)), Ted M. Ross(Cleveland Clinic), Corey J. Crevar(University of Pittsburgh), Donald M. Carter(Vaccine & Gene Therapy Institute of Florida), Rick A. Bright(Waterford Institute), Penny M. Heaton(Johnson & Johnson (Singapore)), Nutan Mytle(Southern Research Institute), Jenna E. Achenbach(Battelle), Terrence M. Tumpey(Centers for Disease Control and Prevention)
Cited by 132
Related Papers
Safety and Efficacy of a Pentavalent Human–Bovine (WC3) Reassortant Rotavirus Vaccine
|New England Journal of Medicine|2006|1.9k
Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern
|The Lancet|2005|734
Adamantane Resistance Among Influenza A Viruses Isolated Early During the 2005-2006 Influenza Season in the United States
|JAMA|2006|672
Transmission of Equine Influenza Virus to Dogs
|Science|2005|652